Cortrium ApS

The Company's aim is to pursue business within the development of medical products, services and related ​​activities.

Description of material changes in activities and finances

The Company's Income Statement of the financial year 1 January 2025 - 31 December 2025 shows a result of ​TDKK -23,885 and the Balance Sheet at 31 December 2025 a balance sheet total of TDKK 52,650 and an equity of ​TDKK 23,894.​​​Management finds the result in accordance with the plan for the year 2025, and is satisfied with the progress and ​development of the company according to the long term plan.

The entity has secured a loan that ensures that the company has sufficient liquidity to meet its obligations as they​fall due during the next 12 months from the balance sheet date.​​No other events have occurred after the balance sheet date to this date, which would influence the evaluation of this annual report.

The entity has secured a loan that ensures that the company has sufficient liquidity to meet its obligations as they ​fall due during the next 12 months from the balance sheet date.

The Entity participates in a Danish joint taxation arrangement where LNZ Holding Zibra ApS serves as the ​administration company. According to the joint taxation provisions ofthe Danish Corporation Tax Act, the Entity ​is therefore liable for income taxes etc for the jointly taxed entities, and for obligations, if any, relating to the ​withholding of tax on interest, royalties and dividend for the jointlytaxed entities. The jointly taxed entities' total ​known net liability under the joint taxation arrangement isdisclosed in the administration company's financial ​statements.

12 Assets charged and collateral

As collateral for the loans from the Export and Investment Fund of Denmark (EIFO) totaling TDKK 4,897 (2024: TDKK 6,881), the Company has a floating company charge of TDKK 5,950 (2024: TDKK 5,950) with collateral in assets with a nominal value of TDKK 24,131 as collateral (2024: TDKK 17,402). The pledged assets comprise of intangible assets, inventories and trade receivables. Further a dividend restriction is established in this regard. The loan is measured at amortised cost.